Perspective slow-release sodium fluoride
β
Charles Y. C. Pak; Joseph E. Zerwekh; Peter P. Antich; Norman H. Bell; Frederick
π
Article
π
2009
π
American Society for Bone and Mineral Research
π
English
β 342 KB
N Now hiiii I< 17. 1995. the FDA Endocrinologic and O M C t , 'I I mlic Drugs Advisory Committee unanimously rccomnicndcd approval of slow-release sodium fluoride (SR-NaF) for the treatment o f postmenopausal osteoporosis. 'l'hc oljcctivc o f this editorial is t o highlight the presentations before